"An epidemiologist who has speculated about whether there is a connection between Covid-19 vaccines and "turbo cancer" in young people, and works as chief epidemiologist at a company that sells ivermectin alongside reviews that claim it has efficacy as a cancer treatment, has been appointed by president Donald Trump to a key position overseeing the National Cancer Program. Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, announced his appointment as chair of the President's Cancer Panel on X earlier this month."
"No formal announcement was made by the president or the White House, and the Cancer Panel website's list of current members does not include Risch. In his new position, Risch will oversee a group which is assigned to monitor "the development and execution of the activities of the National Cancer Program and report to the President on progress, efficacy, and opportunities for improvement," according to the Cancer Panel's website."
Harvey Risch, a professor emeritus of epidemiology at Yale School of Public Health and chief epidemiologist at a company that sells ivermectin, has been appointed chair of the President's Cancer Panel by President Donald Trump. Risch has promoted hydroxychloroquine and ivermectin for Covid-19 and has speculated about a connection between Covid-19 vaccines and "turbo cancer" in young people. No formal announcement accompanied the appointment and the Cancer Panel website's list of current members does not include Risch; the White House, HHS, the Cancer Panel, and Risch did not respond to requests for comment. His role includes monitoring execution of the National Cancer Program and reporting to the president. Experts warned that his appointment could inject conspiracy theories, pseudoscience, and false claims into the panel's work and undermine cancer research and patient care.
Read at WIRED
Unable to calculate read time
Collection
[
|
...
]